GB1508770A - Pharmaceutical compositions - Google Patents
Pharmaceutical compositionsInfo
- Publication number
- GB1508770A GB1508770A GB14265/74A GB1426574A GB1508770A GB 1508770 A GB1508770 A GB 1508770A GB 14265/74 A GB14265/74 A GB 14265/74A GB 1426574 A GB1426574 A GB 1426574A GB 1508770 A GB1508770 A GB 1508770A
- Authority
- GB
- United Kingdom
- Prior art keywords
- digoxin
- pharmaceutical compositions
- digitoxin
- acetyl
- cardiotonic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 abstract 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 abstract 3
- WDJUZGPOPHTGOT-OAXVISGBSA-N Digitoxin Natural products O([C@H]1[C@@H](C)O[C@@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@@](C)([C@H](C6=CC(=O)OC6)CC5)CC4)CC3)CC2)C[C@H]1O)[C@H]1O[C@@H](C)[C@H](O[C@H]2O[C@@H](C)[C@@H](O)[C@@H](O)C2)[C@@H](O)C1 WDJUZGPOPHTGOT-OAXVISGBSA-N 0.000 abstract 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract 2
- 229940097217 cardiac glycoside Drugs 0.000 abstract 2
- 239000002368 cardiac glycoside Substances 0.000 abstract 2
- 230000003177 cardiotonic effect Effects 0.000 abstract 2
- 239000007788 liquid Substances 0.000 abstract 2
- LPMXVESGRSUGHW-HBYQJFLCSA-N ouabain Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@@H]1C[C@@]2(O)CC[C@H]3[C@@]4(O)CC[C@H](C=5COC(=O)C=5)[C@@]4(C)C[C@@H](O)[C@@H]3[C@@]2(CO)[C@H](O)C1 LPMXVESGRSUGHW-HBYQJFLCSA-N 0.000 abstract 2
- 229930002534 steroid glycoside Natural products 0.000 abstract 2
- HPMZBILYSWLILX-UMDUKNJSSA-N 3'''-O-acetyldigitoxin Chemical compound C1[C@H](OC(C)=O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)CC5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O HPMZBILYSWLILX-UMDUKNJSSA-N 0.000 abstract 1
- HPMZBILYSWLILX-UHFFFAOYSA-N Acetyl-digitoxine Natural products C1C(OC(C)=O)C(O)C(C)OC1OC1C(C)OC(OC2C(OC(OC3CC4C(C5C(C6(CCC(C6(C)CC5)C=5COC(=O)C=5)O)CC4)(C)CC3)CC2O)C)CC1O HPMZBILYSWLILX-UHFFFAOYSA-N 0.000 abstract 1
- CKNOLMVLQUPVMU-XOMFLMSUSA-N Digitalin Natural products O(C)[C@H]1[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)[C@H](C)O[C@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@@](C)([C@@H]([C@H](O)C5)C5=CC(=O)OC5)CC4)CC3)CC2)[C@@H]1O CKNOLMVLQUPVMU-XOMFLMSUSA-N 0.000 abstract 1
- LTMHDMANZUZIPE-AMTYYWEZSA-N Digoxin Natural products O([C@H]1[C@H](C)O[C@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@](C)([C@H](O)C4)[C@H](C4=CC(=O)OC4)CC5)CC3)CC2)C[C@@H]1O)[C@H]1O[C@H](C)[C@@H](O[C@H]2O[C@@H](C)[C@H](O)[C@@H](O)C2)[C@@H](O)C1 LTMHDMANZUZIPE-AMTYYWEZSA-N 0.000 abstract 1
- 239000001828 Gelatine Substances 0.000 abstract 1
- JAYAGJDXJIDEKI-UHFFFAOYSA-N Lanatoside C Natural products CC1OC(OC2CC3C(C4C(C5(CCC(C5(C)C(O)C4)C=4COC(=O)C=4)O)CC3)(C)CC2)CC(O)C1OC(OC1C)CC(O)C1OC(OC1C)CC(OC(C)=O)C1OC1OC(CO)C(O)C(O)C1O JAYAGJDXJIDEKI-UHFFFAOYSA-N 0.000 abstract 1
- JAYAGJDXJIDEKI-PTGWOZRBSA-N Lanatoside C Chemical compound O([C@H]1[C@@H](OC(C)=O)C[C@@H](O[C@@H]1C)O[C@H]1[C@@H](O)C[C@@H](O[C@@H]1C)O[C@H]1[C@@H](O)C[C@@H](O[C@@H]1C)O[C@@H]1C[C@@H]2[C@]([C@@H]3[C@H]([C@]4(CC[C@@H]([C@@]4(C)[C@H](O)C3)C=3COC(=O)C=3)O)CC2)(C)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O JAYAGJDXJIDEKI-PTGWOZRBSA-N 0.000 abstract 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 abstract 1
- 239000002202 Polyethylene glycol Substances 0.000 abstract 1
- CPFNIKYEDJFRAT-UHFFFAOYSA-N Strospasid Natural products OC1C(OC)C(O)C(C)OC1OC1CC(CCC2C3(CC(O)C(C3(C)CCC32)C=2COC(=O)C=2)O)C3(C)CC1 CPFNIKYEDJFRAT-UHFFFAOYSA-N 0.000 abstract 1
- CKNOLMVLQUPVMU-UHFFFAOYSA-N UNPD183315 Natural products O1C(C)C(OC2C(C(O)C(O)C(CO)O2)O)C(OC)C(O)C1OC(C1)CCC2(C)C1CCC(C1(CC3O)O)C2CCC1(C)C3C1=CC(=O)OC1 CKNOLMVLQUPVMU-UHFFFAOYSA-N 0.000 abstract 1
- 229960003635 acetyldigitoxin Drugs 0.000 abstract 1
- 229960003304 acetyldigoxin Drugs 0.000 abstract 1
- HWKJSYYYURVNQU-DXJNJSHLSA-N acetyldigoxin Chemical compound C1[C@H](OC(C)=O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)[C@H](O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O HWKJSYYYURVNQU-DXJNJSHLSA-N 0.000 abstract 1
- MGVYFNHJWXJYBE-UHFFFAOYSA-N alpha-Acetyl-digoxin Natural products CC1OC(CC(O)C1O)OC2C(O)CC(OC3C(C)OC(CC3OC(=O)C)OC4CCC5(C)C(CCC6C5CCC7(C)C(C(O)CC67O)C8=CC(=O)OC8)C4)OC2C MGVYFNHJWXJYBE-UHFFFAOYSA-N 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 229950004590 digitalin Drugs 0.000 abstract 1
- CKNOLMVLQUPVMU-YMMLYESFSA-N digitalin Chemical compound C1([C@@H]2[C@@]3(C)CC[C@H]4[C@H]([C@]3(C[C@@H]2O)O)CC[C@H]2[C@]4(C)CC[C@@H](C2)O[C@H]2[C@H](O)[C@H]([C@H]([C@@H](C)O2)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)OC)=CC(=O)OC1 CKNOLMVLQUPVMU-YMMLYESFSA-N 0.000 abstract 1
- 229960000648 digitoxin Drugs 0.000 abstract 1
- WDJUZGPOPHTGOT-XUDUSOBPSA-N digitoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)CC5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O WDJUZGPOPHTGOT-XUDUSOBPSA-N 0.000 abstract 1
- 229960005156 digoxin Drugs 0.000 abstract 1
- LTMHDMANZUZIPE-PUGKRICDSA-N digoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)[C@H](O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O LTMHDMANZUZIPE-PUGKRICDSA-N 0.000 abstract 1
- LTMHDMANZUZIPE-UHFFFAOYSA-N digoxine Natural products C1C(O)C(O)C(C)OC1OC1C(C)OC(OC2C(OC(OC3CC4C(C5C(C6(CCC(C6(C)C(O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)CC2O)C)CC1O LTMHDMANZUZIPE-UHFFFAOYSA-N 0.000 abstract 1
- 229940113088 dimethylacetamide Drugs 0.000 abstract 1
- 229920000159 gelatin Polymers 0.000 abstract 1
- 235000019322 gelatine Nutrition 0.000 abstract 1
- 235000011187 glycerol Nutrition 0.000 abstract 1
- 229960002614 lanatoside c Drugs 0.000 abstract 1
- 229960003746 metildigoxin Drugs 0.000 abstract 1
- IYJMSDVSVHDVGT-PEQKVOOWSA-N metildigoxin Chemical compound O1[C@H](C)[C@@H](OC)[C@@H](O)C[C@@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)[C@H](O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O IYJMSDVSVHDVGT-PEQKVOOWSA-N 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229920001223 polyethylene glycol Polymers 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (12)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB14265/74A GB1508770A (en) | 1974-04-01 | 1974-04-01 | Pharmaceutical compositions |
| DE19752513601 DE2513601A1 (de) | 1974-04-01 | 1975-03-27 | Pharmazeutische praeparate |
| SE7503592A SE408687B (sv) | 1974-04-01 | 1975-03-27 | Forfarande for framstellning av en kardiotonisk doseringsenhet innefattande en mjuk gelatinkapsel, vilken bringas att innehalla en flytande kardiotonisk komposition innefattande en hjertglykosid och polyetenglykol |
| BE154915A BE827349A (fr) | 1974-04-01 | 1975-03-28 | Formes de doses unitaires cardiotoniques comprenant une capsule de gelatine renfermant une composition cardiotonique liquide |
| FR7510180A FR2265353B1 (enExample) | 1974-04-01 | 1975-04-01 | |
| NL7503881A NL7503881A (nl) | 1974-04-01 | 1975-04-01 | Doseringseenheid voor een farmaceutisch prepa- raat. |
| DK138675AA DK137436B (da) | 1974-04-01 | 1975-04-01 | Bæremedium for et hjertestyrkende glycosid. |
| JP3968275A JPS5644045B2 (enExample) | 1974-04-01 | 1975-04-01 | |
| CA223,484A CA1046410A (en) | 1974-04-01 | 1975-04-01 | Cardiotonic composition |
| FI750964A FI63671C (fi) | 1974-04-01 | 1975-04-01 | Foerfarande foer bildande av en doseringsenhetsform av en hjaertmedicin |
| AT244575A AT342777B (de) | 1974-04-01 | 1975-04-01 | Verfahren zur herstellung einer herzstarkenden dosierungseinheit |
| AU79663/75A AU500001B2 (en) | 1974-04-01 | 1975-04-01 | Cardiac glycoside compositions |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB14265/74A GB1508770A (en) | 1974-04-01 | 1974-04-01 | Pharmaceutical compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1508770A true GB1508770A (en) | 1978-04-26 |
Family
ID=10038031
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB14265/74A Expired GB1508770A (en) | 1974-04-01 | 1974-04-01 | Pharmaceutical compositions |
Country Status (12)
| Country | Link |
|---|---|
| JP (1) | JPS5644045B2 (enExample) |
| AT (1) | AT342777B (enExample) |
| AU (1) | AU500001B2 (enExample) |
| BE (1) | BE827349A (enExample) |
| CA (1) | CA1046410A (enExample) |
| DE (1) | DE2513601A1 (enExample) |
| DK (1) | DK137436B (enExample) |
| FI (1) | FI63671C (enExample) |
| FR (1) | FR2265353B1 (enExample) |
| GB (1) | GB1508770A (enExample) |
| NL (1) | NL7503881A (enExample) |
| SE (1) | SE408687B (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6555132B1 (en) | 1993-09-28 | 2003-04-29 | Novartis Ag | Soft gelatin capsule manufacture |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2805165A1 (de) * | 1977-02-09 | 1978-08-10 | Christiaens Sa A | Gitoxin enthaltendes arzneimittel und verfahren zu seiner herstellung |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1481411A (en) * | 1973-07-20 | 1977-07-27 | Scherer Ltd R | Pharmaceutical compositions |
| FR2261752B1 (enExample) * | 1974-02-22 | 1978-07-21 | Wellcome Found |
-
1974
- 1974-04-01 GB GB14265/74A patent/GB1508770A/en not_active Expired
-
1975
- 1975-03-27 SE SE7503592A patent/SE408687B/xx not_active IP Right Cessation
- 1975-03-27 DE DE19752513601 patent/DE2513601A1/de active Granted
- 1975-03-28 BE BE154915A patent/BE827349A/xx not_active IP Right Cessation
- 1975-04-01 AT AT244575A patent/AT342777B/de not_active IP Right Cessation
- 1975-04-01 FR FR7510180A patent/FR2265353B1/fr not_active Expired
- 1975-04-01 JP JP3968275A patent/JPS5644045B2/ja not_active Expired
- 1975-04-01 FI FI750964A patent/FI63671C/fi not_active IP Right Cessation
- 1975-04-01 CA CA223,484A patent/CA1046410A/en not_active Expired
- 1975-04-01 AU AU79663/75A patent/AU500001B2/en not_active Expired
- 1975-04-01 NL NL7503881A patent/NL7503881A/xx not_active Application Discontinuation
- 1975-04-01 DK DK138675AA patent/DK137436B/da not_active IP Right Cessation
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6555132B1 (en) | 1993-09-28 | 2003-04-29 | Novartis Ag | Soft gelatin capsule manufacture |
| US7078054B2 (en) | 1993-09-28 | 2006-07-18 | Novartis Ag | Soft gelatin capsule manufacture |
Also Published As
| Publication number | Publication date |
|---|---|
| DK138675A (enExample) | 1975-10-02 |
| FR2265353B1 (enExample) | 1980-02-15 |
| AT342777B (de) | 1978-04-25 |
| FI63671C (fi) | 1983-08-10 |
| JPS5644045B2 (enExample) | 1981-10-16 |
| DE2513601C2 (enExample) | 1988-05-26 |
| NL7503881A (nl) | 1975-10-03 |
| SE408687B (sv) | 1979-07-02 |
| FR2265353A1 (enExample) | 1975-10-24 |
| DK137436B (da) | 1978-03-06 |
| FI750964A7 (enExample) | 1975-10-02 |
| DK137436C (enExample) | 1978-08-21 |
| DE2513601A1 (de) | 1975-10-02 |
| AU500001B2 (en) | 1979-05-10 |
| JPS517117A (enExample) | 1976-01-21 |
| ATA244575A (de) | 1977-08-15 |
| FI63671B (fi) | 1983-04-29 |
| AU7966375A (en) | 1976-10-07 |
| BE827349A (fr) | 1975-09-29 |
| SE7503592L (enExample) | 1975-10-02 |
| CA1046410A (en) | 1979-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL46967A (en) | N-pyrrolidyl-, n-piperidyl-,n-pyridyl-and n-pyrroly-polyfluoroalkyl-benzamide derivatives, their preparation and pharmaceutical compositions comprising them | |
| AU461863B2 (en) | Propanolamine derivatives, their preparation and therapeutic compositions containing thesame | |
| SE8402551D0 (sv) | Cinnamoylmoranolin-derivat | |
| IL48593A (en) | 1-substituted-4-benzylidenepiperidine derivatives, their preparation and pharmaceutical compositions comprising them | |
| IT1129756B (it) | Procedimento per la preparazione di latici di copolimeri acetato di vinile/etilene e latici ottenuti mediante detto procedimento | |
| IL40376A0 (en) | Pharmaceutical compositions containing an estrogenic and a progestational substance | |
| BE848496A (fr) | Derives d'amino-alcools, leur preparation et utilisation, ainsi que compositions contenant ces derives. | |
| SE419825B (sv) | Anordning for bearbetning av emnen, exempelvis blandning av kornformiga, pulverformiga eller pastaartade emnen och/eller vetskor | |
| SE7506766L (sv) | Makromolekylera adeninderivat samt forfarande for framstellning av desamma. | |
| NL7513746A (nl) | (beta)-lactam-antibiotica, werkwijzen ter bereiding alsmede de toepassing ervan als geneesmiddelen. | |
| SE7409203L (enExample) | ||
| IL52041A (en) | Quinazoline derivatives,their preparation and pharmaceutical compositions containing them | |
| IL51694A (en) | 1-azacarbocyclic-2-ylidene derivatives of guanidine,their preparation and pharmaceutical compositions containing them | |
| IL48678A0 (en) | N-(2-pyrrolidinylmethyl)-2-methoxybenzamide derivatives,their preparation and pharmaceutical compositions containing them | |
| SE7503592L (enExample) | ||
| IL52857A (en) | Oxo-benzopyrane derivatives,their preparation and pharmaceutical compositions containing them | |
| NO146711C (no) | Analogifremgangsmaate for fremstilling av oleandomycin- og erytromycinderivater. | |
| DE2960506D1 (en) | Arylimidazoles, their synthesis and pharmaceutical or veterinary preparations containing them | |
| SE420919B (sv) | Forfarande for framstellning av n?722-dansyl-l-argininderivat och farmaceutiskt godtagbara syradditionssalter derav | |
| IL41396A0 (en) | Novel oxazolidinones and thiazolidinones,their preparation and pharmaceutical compositions containing them | |
| IL48063A (en) | 2-(tert.-butylaminomethyl)benzo-furanmethanol derivatives,their manufacture and pharmaceutical compositions containing | |
| SE7509441L (sv) | Athelminitiskt aktiva 2-karbalkoxiamino-bensimidazolyl-5(6)-sulfonsyra-fenylestrar och forfarande for deras framstellning | |
| IL56913A0 (en) | Steroid spiro oxazolidinone derivatives,their preparation and pharmaceutical compositions containing them | |
| IL51998A (en) | 7-chloro-3-alkoxycarbonyl-5-halophenyl-2-oxo-2,3-dihydro-1,4-benzodiazepine derivatives,their preparation and pharmaceutical compositions containing them | |
| CA871155A (en) | Optically active phenyl isopropylamine derivatives having pharmaceutical properties and their preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| PCNP | Patent ceased through non-payment of renewal fee |